Acute Respiratory Distress Syndrome (ARDS): Mechanism

1. Initiating Insults — Direct vs. Indirect Pathways

2. The Alveolar-Capillary Barrier — The Central Target

• Type I pneumocytes (95% of surface area, thin gas exchange cells — highly vulnerable)
• Type II pneumocytes (surfactant producers, progenitor cells for repair)
• Pulmonary capillary endothelium
• Shared basement membrane

3. The Inflammatory Cascade

A. Macrophage Activation & Cytokine Storm

• Alveolar macrophages recognize pathogen-associated molecular patterns (PAMPs, e.g., LPS) and damage-associated molecular patterns (DAMPs) via Toll-like receptors (TLRs)
• Activated macrophages release TNF-α, IL-1β, IL-6, IL-8 (CXCL8), and other pro-inflammatory cytokines
• These act as chemoattractants, pulling circulating neutrophils into the lung

B. Neutrophil Accumulation and Activation

1. Margination — Neutrophils adhere to injured endothelium via upregulated adhesion molecules (ICAM-1, selectins)
2. Transmigration — They cross the endothelium and epithelium into the alveolar space, driven by IL-8 and other chemokines
3. Activation — Release destructive mediators including:
   • Reactive oxygen species (ROS) — oxidative damage to membranes and proteins
   • Proteases (elastase, MMP-8, MMP-9) — degrade basement membrane and tight junctions
   • Myeloperoxidase — generates hypochlorous acid (HOCl)
   • Platelet-activating factor (PAF) and leukotrienes — amplify vascular permeability

C. Lipid Mediators

• Phospholipase A2 (especially in pancreatitis) degrades surfactant phospholipids and directly increases vascular permeability
• Leukotriene B4 (LTB4) is a potent neutrophil chemoattractant
• PAF promotes platelet aggregation and neutrophil activation

D. Coagulation-Inflammation Cross-talk

• Plasma proteins leaking into alveoli activate the coagulation cascade
• Fibrin deposition forms hyaline membranes (the histologic hallmark of DAD)
• Tissue factor is upregulated on macrophages and endothelium
• Simultaneous inhibition of fibrinolysis (↑PAI-1) traps fibrin in alveoli
• Platelet aggregation within microvessels contributes to microvascular thrombosis and dead-space ventilation

E. Angiopoietins

• Angiopoietin-2 (Ang-2) is released from activated endothelium (Weibel-Palade bodies), competitively inhibiting Tie-2 receptor signaling and destabilizing endothelial junctions
• Elevated Ang-2 is a biomarker of endothelial activation in ARDS
• Ang-1 (from pericytes) opposes this and promotes barrier stability

4. Diffuse Alveolar Damage — The Pathological Result

Histology showing thickened alveolar walls, hyaline membranes (arrow), and organizing fibrosis alongside bilateral CT opacities — the radiological-pathological hallmarks of ARDS/DAD.

5. Surfactant Dysfunction

• ARDS dramatically impairs surfactant function through multiple mechanisms:
  • Type II pneumocyte injury → reduced surfactant production (phosphatidylcholine, SP-B, SP-C)
  • Phospholipase A2 → enzymatic degradation of existing surfactant
  • Plasma protein leak (albumin, fibrin) into alveoli → inactivation of surfactant function
• Loss of surfactant raises alveolar surface tension → alveolar collapse (atelectasis) → reduced functional residual capacity (FRC) → severe hypoxemia

6. Sodium/Water Transport Failure

• Apoptosis and necrosis of alveolar epithelium destroy this machinery
• Proinflammatory cytokines, oxidants, and hypoxia impair transcellular ion transport
• AFC rate falls dramatically → fluid accumulates and worsens gas exchange — Fishman's, p. 2484

7. Ventilator-Induced Lung Injury (VILI) — A Compounding Mechanism

• Volutrauma/barotrauma — overdistension of open lung units at high tidal volumes
• Atelectrauma — repetitive collapse and reopening of dependent lung units
• Both mechanisms trigger biotrauma — cytokine release (TNF-α, IL-6, IL-8) that can spill into the systemic circulation, driving multi-organ failure

Summary Diagram of Pathogenesis

Direct insult (pneumonia, aspiration)
         ↓
Indirect insult (sepsis, pancreatitis)
         ↓
Alveolar macrophage activation (TLR → TNF-α, IL-1β, IL-6, IL-8)
         ↓
Neutrophil margination, transmigration, activation
         ↓
ROS + proteases → tight junction disruption
         ↓
Alveolar-capillary barrier breach → protein-rich edema floods alveoli
         ↓
Type I cell necrosis + Type II cell injury → surfactant failure
         ↓
ENaC dysfunction → impaired fluid clearance
         ↓
Coagulation activation → fibrin/hyaline membranes
         ↓
Diffuse alveolar damage: bilateral opacities, severe hypoxemia, ↓compliance
         ↓         ↑
VILI (if high tidal volume)

Key Biomarkers Reflecting These Mechanisms

• Fishman's Pulmonary Diseases and Disorders — Mechanisms of ARDS chapter, pp. 2480–2485
• Murray & Nadel's Textbook of Respiratory Medicine — Etiology and Pathogenesis of ARDS chapter
• Sabiston Textbook of Surgery — ARDS, p. 940
• Goldman-Cecil Medicine — Chapter 90/91